News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zealand Pharma - Interim Report for H1 2012 (Unaudited)


8/24/2012 9:30:35 AM

COPENHAGEN, Denmark, Aug. 23, 2012 (GLOBE NEWSWIRE) -- Zealand Pharma A/S (Copenhagen:ZEAL), a biotech company dedicated to the discovery and development of peptide drugs, reports revenue growth, a net profit and an increase in cash and securities combined with the achievement of several important pipeline milestones for the six month period 1 January to 30 June 2012.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES